Cappuzzo F.; Varella-Garcia M.; Finocchiaro G.; Skokan M.; Gajapathy S.; Carnaghi C.; Rimassa L.; Rossi E.; Ligorio C.; Di Tommaso L.; Holmes A.J.; Toschi L.; Tallini G.; Destro A.; Roncalli M.; Santoro A.; Jänne P.A., Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients., «BRITISH JOURNAL OF CANCER», 2008, 99, pp. 83 - 89 [articolo]
Frau DV; Lai M.L.; Caria P.; Dettori T.; Coni P.; Faa G.; Morandi L.; Tallini G.; Vanni R., Trisomy 17 as a Marker For A Subset of Noninvasive Thyroid Nodules With Focal Features of Papillary Carcinoma: Cytogenetic and Molecular Analysis of 62 Cases and Correlation with Histologic Findings, «THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM», 2008, 93, pp. 177 - 181 [articolo]
Gasparre G.; Porcelli A.M.; Bonora E.; Pennisi L.F.; Toller M.; Iommarini L.; Ghelli A.; Moretti M.; Betts C.M.; Martinelli G.N.; Ceroni A.R.; Curcio F.; Carelli V.; Rugolo M.; Tallini G.; Romeo G., Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumours., «PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA», 2007, 104, pp. 9001 - 9006 [articolo]
Coordinamento del progetto: Espressione del NIS (Sodium/Iodide Symporter) nei tumori tiroidei ed extratiroidei: correlazione con caratteristiche clinicopatologiche e molecolari.
Franceschi E; Cavallo G; Lonardi S; Magrini E; Tosoni A; Grosso D; Scopece L; Blatt V; Urbini B; Pession A; Tallini G; Crino L; Brandes AA, Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO), «BRITISH JOURNAL OF CANCER», 2007, 96, pp. 1047 - 1051 [articolo]
Hou P.; Liu D.; Shan Y.; Hu S.; Studeman K.; Condouris S.; Wang Y.; Trink A.; El-Naggar A.K.; Tallini G.; Vasko V.; Xing M., Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer., «CLINICAL CANCER RESEARCH», 2007, 13, pp. 1161 - 1170 [articolo]
Ruolo editoriale nella rivista «Journal of Molecular Diagnostics», AMSTERDAM, Elsevier
Floris G.; Debiec-Rychter M.; Wozniak A.; Magrini E.; Manfioletti G.; De Wever I.; Tallini G.; Sciot R., Malignant Ectomesenchymoma: Genetic Profile Reflects Rhabdomyosarcomatous Differentiation., «DIAGNOSTIC MOLECULAR PATHOLOGY», 2007, 16, pp. 243 - 248 [articolo]
Tallini G; Hui P., Molecular Diagnostic Pathology of Sarcomas, in: Molecular Pathology in Clinical Practice, NEW YORK, Springer-Verlag, 2007, pp. 287 - 297 [capitolo di libro]
L. Morandi; D. Ferrari; C. Lombardo; A. Pession; G. Tallini, Monitoring HCV RNA viral load by locked nucleic acid molecular beacons real time PCR, «JOURNAL OF VIROLOGICAL METHODS», 2007, 140, pp. 148 - 154 [articolo]
Visone R.; Pallante P.; Vecchione A.; Cirombella R.; Ferracin M.; Ferraro A.; Volinia S.; Coluzzi S.; Leone V.; Borbone E.; Liu C.G.; Petrocca F.; Troncone G.; Calin G.A.; Scarpa A.; Colato C.; Tallini G.; Santoro M.; Croce C.M.; Fusco A., Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007;26:7590-7595., «ONCOGENE», 2007, 26, pp. 7590 - 7595 [articolo]
Ghossein R.A.; Leboeuf R.; Patel K.N.; Rivera M.; Katabi N.; Carlson D.L.; Tallini G.; Shaha A.; Singh B.; Tuttle R.M., Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications., «THYROID», 2007, 17, pp. 655 - 661 [articolo]
Hu S.; Liu D.; Tufano R.P.; Carson KA; Rosenbaum E; Cohen Y; Holt EH; Kiseljak-Vassiliades K; Rhoden KJ; Tolaney S; Condouris S; Tallini G.; Westra W.H.; Umbricht CB; Zeiger MA; Califano JA; Vasko V; Xing M, Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer, «INTERNATIONAL JOURNAL OF CANCER», 2006, 119, pp. 2322 - 2329 [articolo]
Cappuzzo F.; Finocchiaro G.; Metro G.; Bartolini S.; Magrini E.; Cancellieri A.; Trisolini R.; Castaldini L.; Tallini G.; Crino L., Clinical experience with gefitinib: an update, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2006, 58, pp. 31 - 45 [articolo]
BONORA E.; PORCELLI A.M.; GASPARRE G.; BIONDI A.; GHELLI A.; CARELLI V.; BARACCA A.; TALLINI G.; MARTINUZZI A.; LENAZ G.; RUGOLO M.; ROMEO G., Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III, «CANCER RESEARCH», 2006, 66, pp. 6087 - 6096 [articolo]
